GRB2 and metastatic malignant neoplasm in the lymph nodes: For example, increased expression of GRB2 is linked to poor survival in patients with gastric cancer8, and overexpression of GRB2 is associated with lymph node metastasis and shorter survival in patients with esophageal cancer9.